Healthy Living: Alzheimer’s Study

5.5 million Americans have Alzheimer’s disease.

It’s a condition that has no cure right now, and very few treatments.

Now, in a first-of-its kind trial, researchers are testing a drug they hope will stop the disease in its tracks before damage begins.

Courtney Hunter explains in Health Living.

Researchers are now enrolling participants in ahead 3-45 trials.

They are looking to test antibodies in even younger participants-starting at age 50.

Researchers are also hoping to enroll people interested in Alzheimer’s prevention in the APT web study, which will help screen for future participants.

Categories: Healthy Living